谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Durvalumab Versus Chemotherapy As First-line Treatment for Metastatic NSCLC with Tumor PD-L1 Expression ≥25%: Results from the Randomized Phase 3 PEARL Study

Shun Lu,Lin Wu,Qiming Wang,Ziping Wang,Dongqing Lv,Rui Ma,Bo Zhu,Ngoc van Tran,Liyan Jiang,Kejun Nan,Konstantin Laktionov,Stephen Clarke, Minghao Song,Helen Mann, Yinglei Liu,Xiaojin Shi,Yi-Long Wu

Journal of Thoracic Oncology（2024）

引用 0|浏览0
关键词
Durvalumab,PEARL,metastatic NSCLC,chemotherapy,PD-L1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要